1. Home
  2. NSPR vs AIRE Comparison

NSPR vs AIRE Comparison

Compare NSPR & AIRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • AIRE
  • Stock Information
  • Founded
  • NSPR 2005
  • AIRE 2021
  • Country
  • NSPR Israel
  • AIRE United States
  • Employees
  • NSPR N/A
  • AIRE 14
  • Industry
  • NSPR Medical/Dental Instruments
  • AIRE
  • Sector
  • NSPR Health Care
  • AIRE
  • Exchange
  • NSPR Nasdaq
  • AIRE Nasdaq
  • Market Cap
  • NSPR 63.0M
  • AIRE 53.2M
  • IPO Year
  • NSPR N/A
  • AIRE N/A
  • Fundamental
  • Price
  • NSPR $2.93
  • AIRE $1.20
  • Analyst Decision
  • NSPR Strong Buy
  • AIRE Strong Buy
  • Analyst Count
  • NSPR 2
  • AIRE 1
  • Target Price
  • NSPR $4.75
  • AIRE $3.00
  • AVG Volume (30 Days)
  • NSPR 78.6K
  • AIRE 64.9K
  • Earning Date
  • NSPR 11-12-2024
  • AIRE 12-24-2024
  • Dividend Yield
  • NSPR N/A
  • AIRE N/A
  • EPS Growth
  • NSPR N/A
  • AIRE N/A
  • EPS
  • NSPR N/A
  • AIRE N/A
  • Revenue
  • NSPR $6,821,000.00
  • AIRE $379,241.00
  • Revenue This Year
  • NSPR $13.31
  • AIRE $571.65
  • Revenue Next Year
  • NSPR $52.91
  • AIRE $168.35
  • P/E Ratio
  • NSPR N/A
  • AIRE N/A
  • Revenue Growth
  • NSPR 24.70
  • AIRE 18.11
  • 52 Week Low
  • NSPR $1.81
  • AIRE $0.53
  • 52 Week High
  • NSPR $3.42
  • AIRE $3.10
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 52.69
  • AIRE 55.31
  • Support Level
  • NSPR $2.78
  • AIRE $1.14
  • Resistance Level
  • NSPR $3.15
  • AIRE $1.23
  • Average True Range (ATR)
  • NSPR 0.22
  • AIRE 0.07
  • MACD
  • NSPR -0.03
  • AIRE 0.00
  • Stochastic Oscillator
  • NSPR 47.58
  • AIRE 63.16

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company that develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability; and has an app for investment into the properties that it purchased aimed at retail investors. The company's reportable segments are; Platform Services, which derives key revenue, and the Rental business segment.

Share on Social Networks: